Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 254 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q4
GUIDEWELL MUTUAL HOLDING CORPORATION for GUIDEWELL MUTUAL HOLDING CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · Florida · House · Senate
Medicare/Medicaid, Pharmacy
View →
Q4
NATIONAL HEALTH COUNCIL for NATIONAL HEALTH COUNCIL
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View →
Q4
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · Senate · $60,000.00 income
Pharmacy
View →
Q4
PORTERFIELD, FETTIG & SEARS, LLC for NATIONAL BRAIN TUMOR SOCIETY
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $20,000.00 income
Health Issues
View →
Q4
BLUE CROSS AND BLUE SHIELD ASSOCIATION for BLUE CROSS AND BLUE SHIELD ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid
View →
Q4
AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View →
Q4
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Defense
View →
Q4
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q4
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues
View →
Q4
TWENTY-FIRST CENTURY GROUP, INC. for RAFAEL HOLDINGS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $24,000.00 income
Health Issues
View →
Q4
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate
Pharmacy
View →
Q4
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q4
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $80,000.00 income
Health Issues
View →
Q4
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q4
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View →
Q4
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q4
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q4
LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $30,000.00 income
Health Issues
View →
Q4
LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $50,000.00 income
Health Issues
View →
Q4
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q4
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate
Health Issues
View →
Q4
HOLLAND & KNIGHT LLP for BLACK WOMEN'S HEALTH IMPERATIVE
4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate · $20,000.00 income
Health Issues
View →
RR
THE VOGEL GROUP for FORTRESS BIOTECH INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Florida
Health Issues
View →
Previous Page 5 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem